Free Trial
OTCMKTS:FSPKF

Fisher & Paykel Healthcare (FSPKF) Stock Price, News & Analysis

Fisher & Paykel Healthcare logo
$18.36 0.00 (0.00%)
As of 05/1/2025

About Fisher & Paykel Healthcare Stock (OTCMKTS:FSPKF)

Key Stats

Today's Range
$18.36
$18.36
50-Day Range
$16.35
$22.00
52-Week Range
$16.35
$25.91
Volume
N/A
Average Volume
1,200 shs
Market Capitalization
N/A
P/E Ratio
108.23
Dividend Yield
0.36%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fisher & Paykel Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

FSPKF MarketRank™: 

Fisher & Paykel Healthcare scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Fisher & Paykel Healthcare.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fisher & Paykel Healthcare is 108.23, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.88.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fisher & Paykel Healthcare is 108.23, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.71.

  • Read more about Fisher & Paykel Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 854.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Fisher & Paykel Healthcare has recently decreased by 23.90%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Fisher & Paykel Healthcare pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fisher & Paykel Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fisher & Paykel Healthcare is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Fisher & Paykel Healthcare's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Fisher & Paykel Healthcare has a short interest ratio ("days to cover") of 854.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Fisher & Paykel Healthcare has recently decreased by 23.90%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Fisher & Paykel Healthcare has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.83 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Fisher & Paykel Healthcare this week, compared to 0 articles on an average week.
Receive FSPKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

FSPKF Stock News Headlines

Trump Makes Major Crypto Announcement
Trump's Pro-Crypto Agenda Finally Sparks Market Recovery With Bitcoin surging past $90,000 and altcoins heating up, I'm seeing all the signs of a major market shift For a limited time, I'm revealing the name and complete analysis behind my top Trump-era crypto pick.
PT Perusahaan Gas Negara Tbk (PGB1.BE)
Fisher & Paykel Healthcare Corporation LtdShs
See More Headlines

FSPKF Stock Analysis - Frequently Asked Questions

Fisher & Paykel Healthcare's stock was trading at $25.91 at the beginning of 2025. Since then, FSPKF stock has decreased by 29.1% and is now trading at $18.36.
View the best growth stocks for 2025 here
.

Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/02/2025
Next Earnings (Estimated)
5/27/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:FSPKF
CIK
N/A
Fax
N/A
Employees
6,391
Year Founded
N/A

Profitability

Trailing P/E Ratio
108.23
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:FSPKF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners